ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer

Anke Bill(Novartis (China)), L. Alex Gaither(Pathways Behavioral Services), Débora Bonenfant(Novartis (Switzerland)), Umamaheswar Duvvuri(City University of New York), Carolyn Kemp(University of Pittsburgh Medical Center), Hans Voshol(Novartis (Switzerland)), Sucheta Kulkarni(University of Pittsburgh Medical Center), Abraham Gutierrez

Oncotarget

March 16, 2015

10.18632/oncotarget.3277

Cited by 110

Related Papers

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

|Immunity|2020|688

Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

|Cancer Discovery|2013|590

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

|Cancer|2014|502

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

|Thyroid|2015|393

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

|Nature Communications|2021|365